Immune System News and Research

RSS

New understanding of the disease process involved in atherosclerosis

The progression of the artery-clogging disease atherosclerosis is linked to the inability of specialized bone marrow cells to continuously repair damage to the arterial lining, Duke University Medical Center researchers have demonstrated.

13 Nov 2005

Maternal malaria and gravidity interact to modify infant susceptibility to malaria

Every year at least 30 million women in malaria-endemic areas of Africa become pregnant. Many of them develop placental malaria, a pregnancy-specific form of the disease, which frequently results in low birth weight of the child.

13 Nov 2005

Promising functional readouts of immunity in a blood-stage malaria vaccine trial

A malaria vaccine remains the most desired tool to combat the worsening malaria epidemic in many developing countries. Pierre Druilhe and colleagues (from the Institut Pasteur in Paris) have completed the first human trial of a vaccine based on MSP3, a protein present on the surface of the malaria parasite, with very encouraging results.

13 Nov 2005

Flu expert calls for mandatory vaccination of health care workers

Johns Hopkins' senior hospital epidemiologist and flu expert is calling for mandatory vaccination of all health care workers as the best means of protecting patients and hospital staff from widespread outbreaks of the viral illness.

10 Nov 2005

Vaccine for a type of blood cancer - follicular lymphoma

A team of researchers has demonstrated the clinical efficacy and benefits of a vaccine for a type of blood cancer, follicular lymphoma, amongst first time relapse patients. Specialists from two University of Navarre centres – the University Hospital and the Research Centre for Applied Medicine (CIMA) - have worked jointly since 2001 on the research.

9 Nov 2005

Chlamydia pneumoniae may cause vision problems

Researchers at the Massachusetts Eye and Ear Infirmary (MEEI) have found that Chlamydia pneumoniae, a bacterium linked to heart disease and capable of causing chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or "wet," age-related macular degeneration (AMD).

7 Nov 2005

Tiny worms provide clues to new treatments for diabetes, asthma and hay fever

University of Edinburgh scientists, who have discovered that helminth parasites can exploit an 'Achilles heel' in our immune system, now hope to mimic the worms' survival tactics in a bid to beat infection.

7 Nov 2005

Research project to advance understanding of how cancer cells evade the immune system

A pre-clinical research project coordinated by The University of Manchester, which will advance understanding of how cancer cells evade the immune system, has been awarded nearly 12m Euro by the EU.

From The University of Manchester 7 Nov 2005

Hurricane Katrina leaves behind a cough as well as destruction

In the wake of hurricane Katrina some survivors have developed a cough now dubbed 'Katrina Cough'.

7 Nov 2005

Exposure to movie smoking accounts for smoking initiation among over one-third of U.S. adolescents

The first national study to look at the connection between smoking in movies and smoking initiation among adolescents shows that exposure to smoking in popular films is a primary risk factor in determining whether young people will start smoking.

7 Nov 2005

HIV antiretroviral therapy does help those in third world

With preliminary results from a study in Botswana, Harvard School of Public Health researchers have found that people with HIV-1 subtype C in resource-poor settings, who receive antiretroviral (ARV) therapy, can achieve comparable results to those in the developed world.

7 Nov 2005

HIV-positive patients have shorter survival periods while awaiting liver transplants

A new study on HIV-positive patients eligible for liver transplants found that their survival while waiting for a transplant is significantly shorter than patients who are HIV-negative.

7 Nov 2005

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

7 Nov 2005

Scientists find new mechanism by which brain cells can be damaged during chronic neurodegenerative diseases

Scientists at the University of Rochester Medical Center have targeted a new culprit and method of attack on neurologic functions in diseases such as Alzheimer's and dementia associated with HIV.

7 Nov 2005

Tryptophan metabolites play an important role in the immune system

Tryptophan is the source of Thanksgiving legend and grist for a "Seinfeld" episode, but it's not the chemical that you'd expect to find in Lawrence Steinman's lab.

7 Nov 2005

Vaccine that targets nicotine rather than the brain's reaction to it

Since smoking became popular in America in the 1930s, lung cancer rates have continued to climb. Today, it is still the leading cause of cancer-related deaths, with totals more than the other five leading cancers combined.

3 Nov 2005

Targeted drug delivery now possible using nanoparticle-apatamer conjugates

Ground-breaking results from researchers at Harvard Medical School and Massachusetts Institute of Technology (MIT), USA, disclosed at the 13th European Cancer Conference (ECCO) have shown for the first time that targeted drug delivery is possible using nanoparticle-apatamer conjugates.

3 Nov 2005

Withdrawn MS drug works for Crohn's sufferers

Researchers say that a multiple sclerosis drug that was withdrawn from the market for safety reasons, has shown some effectiveness against the painful bowel disorder Crohn's disease.

3 Nov 2005

Cancer Vaccine - Synthetically generated glycopeptides from tumor cells can stimulate the formation of specific antibodies

Tumor cells and healthy somatic cells differ in the structures on their surfaces. In principle, it should thus be possible to develop a vaccine that causes a patient’s immune system to form antibodies that attack and destroy tumor cells while sparing healthy cells.

3 Nov 2005

Updated vaccine against cervical cancer provides longer sustainable response

Drug company GlaxoSmithKline says that it's updated vaccine against the human papillomavirus (HPV), has produced a stronger immune response, than the original formula of the vaccine.

2 Nov 2005

Immune System News and Research

New understanding of the disease process involved in atherosclerosis

Maternal malaria and gravidity interact to modify infant susceptibility to malaria

Promising functional readouts of immunity in a blood-stage malaria vaccine trial

Flu expert calls for mandatory vaccination of health care workers

Vaccine for a type of blood cancer - follicular lymphoma

Chlamydia pneumoniae may cause vision problems

Tiny worms provide clues to new treatments for diabetes, asthma and hay fever

Research project to advance understanding of how cancer cells evade the immune system

Hurricane Katrina leaves behind a cough as well as destruction

Exposure to movie smoking accounts for smoking initiation among over one-third of U.S. adolescents

HIV antiretroviral therapy does help those in third world

HIV-positive patients have shorter survival periods while awaiting liver transplants

Study proves the effectiveness of Vfend for the treatment of candidemia

Scientists find new mechanism by which brain cells can be damaged during chronic neurodegenerative diseases

Tryptophan metabolites play an important role in the immune system

Vaccine that targets nicotine rather than the brain's reaction to it

Targeted drug delivery now possible using nanoparticle-apatamer conjugates

Withdrawn MS drug works for Crohn's sufferers

Cancer Vaccine - Synthetically generated glycopeptides from tumor cells can stimulate the formation of specific antibodies

Updated vaccine against cervical cancer provides longer sustainable response

Understanding the DNA Damage Response in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News